Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults

NCT03026348 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Viruses

Interventions

BIOLOGICAL: RSV F Vaccine with Aluminum Phosphate Adjuvant
BIOLOGICAL: RSV F Vaccine
BIOLOGICAL: Matrix-M1 Adjuvant
OTHER: Phosphate Buffer

Sponsor

Novavax